Moleculin Biotech's market cap is currently ―. The company's EPS TTM is $-15.097; its P/E ratio is -0.28; Moleculin Biotech is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-3.53. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	-	-	-	$ 0.00	$ 0.00
Gross Profit	-	$ 12.00K	$ -32.00K	-	-
EBIT	$ -5.98M	$ 8.79M	$ -6.90M	$ -9.08M	$ -7.43M
EBITDA	-	$ 8.82M	$ -6.86M	$ -9.05M	$ -7.40M
Net Income Common Stockholders	$ -5.98M	$ 8.79M	$ -6.77M	$ -8.61M	$ -6.78M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 32.17M	$ 37.27M	$ 43.15M	$ 50.39M	$ 58.00M
Total Assets	$ 47.12M	$ 50.82M	$ 57.42M	$ 65.37M	$ 73.25M
Total Debt	$ 291.00K	$ 308.00K	$ 335.00K	$ 477.00K	$ 486.00K
Net Debt	$ -31.88M	$ -36.96M	$ -42.81M	$ -49.91M	$ -57.51M
Total Liabilities	$ 6.85M	$ 5.39M	$ 5.23M	$ 6.96M	$ 6.90M
Stockholders Equity	$ 40.27M	$ 45.68M	$ 52.19M	$ 58.42M	$ 66.36M
Cash Flow	-
Free Cash Flow	-	$ -6.02M	$ -7.26M	$ -7.58M	$ -8.06M
Operating Cash Flow	$ -5.13M	$ -6.02M	$ -7.26M	$ -7.58M	$ -8.00M
Investing Cash Flow	$ -15.00K	-	-	$ 0.00	$ -61.00K
Financing Cash Flow	$ 49.00K	$ 141.00K	-	$ -11.00K	$ -12.00K

Currency in USD

Moleculin Biotech Earnings and Revenue History

Income Statement >

Moleculin Biotech Debt to Assets

Balance Sheet >

Moleculin Biotech Cash Flow

Cash Flow >

Moleculin Biotech Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing